We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

96 hedge funds and large institutions have $51.5M invested in G1 Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more call options, than puts

Call options by funds: $431K | Put options by funds: $121K

16% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 37

17% less funds holding

Funds holding: 116 → 96 (-20)

58% less capital invested

Capital invested by funds: $123M → $51.5M (-$71.7M)

63% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 30

Holders
96
Holders Change
-20
Holders Change %
-17.24%
% of All Funds
1.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
31
Reduced
37
Closed
30
Calls
$431K
Puts
$121K
Net Calls
+$310K
Net Calls Change
+$101K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.3M
2
Bank of America
Bank of America
North Carolina
+$1.67M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$1.33M
4
RJA
Raymond James & Associates
Florida
+$1.19M
5
XT
XTX Topco
Cayman Islands
+$923K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.83M
2
MB
MPM BioImpact
Massachusetts
-$3.53M
3
WP
Woodline Partners
California
-$3.5M
4
RPAM
Rhenman & Partners Asset Management
Sweden
-$2.01M
5
CA
CHI Advisors
New York
-$1.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Voloridge Investment Management
101
Voloridge Investment Management
Florida
– -$820K -150,930 Closed
BC
102
BIT Capital
Germany
– -$748K -137,746 Closed
E
103
Ergoteles
New York
– -$629K -115,751 Closed
Bank of Montreal
104
Bank of Montreal
Ontario, Canada
– -$596K -109,339 Closed
Mackenzie Financial
105
Mackenzie Financial
Ontario, Canada
– -$421K -77,450 Closed
EGM
106
Engineers Gate Manager
New York
– -$253K -46,551 Closed
JF
107
Jump Financial
Illinois
– -$242K -44,603 Closed
State of Wisconsin Investment Board
108
State of Wisconsin Investment Board
Wisconsin
– -$233K -42,951 Closed
TI
109
Trexquant Investment
Connecticut
– -$214K -39,465 Closed
Acadian Asset Management
110
Acadian Asset Management
Massachusetts
– -$165K -30,475 Closed
CNBT
111
Cornerstone National Bank & Trust
Illinois
– -$136K -25,000 Closed
AGM
112
Alpine Global Management
New York
– -$131K -24,085 Closed
FRM
113
Fox Run Management
Connecticut
– -$128K -23,542 Closed
CANY
114
Caxton Associates (New York)
New York
– -$98.2K -18,093 Closed
PAM
115
PVG Asset Management
Colorado
– -$84.6K -15,585 Closed
ECM
116
ExodusPoint Capital Management
New York
– -$75K -13,856 Closed
Balyasny Asset Management
117
Balyasny Asset Management
Illinois
– -$71.9K -13,241 Closed
MFS
118
Mirabella Financial Services
United Kingdom
– -$67.9K -12,509 Closed
Lazard Asset Management
119
Lazard Asset Management
New York
– -$54K -10,012 Closed
Simplex Trading
120
Simplex Trading
Illinois
– -$45.6K -9,496 Closed
SOW
121
State of Wyoming
Wyoming
– -$11.3K -2,086 Closed
ACM
122
Aquatic Capital Management
Illinois
– -$11K -2,000 Closed
First Manhattan
123
First Manhattan
New York
– -$3.87K -712 Closed
Toronto Dominion Bank
124
Toronto Dominion Bank
Ontario, Canada
– -$1K -200 Closed
QCG
125
Quadrant Capital Group
Ohio
– -$706 -130 Closed
1 2 3 4
5

GTHX Hedge Fund Activity: Q1 2023 in Review

96 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q1 2023, worth a combined $51.5M — down 58% from $123M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of GTHX and 11 opened new positions — a net loss of 19 holders — while 37 trimmed existing stakes and 31 added.

The largest buyer was Fidelity Investments, adding an estimated $3.3M. The largest seller was Millennium Management, cutting an estimated $3.83M.

  • 96 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q1 2023, down from 116 in Q4 2022.
  • Funds reported $51.5M of G1 Therapeutics, Inc. Common Stock stock for Q1 2023, down 58% quarter-over-quarter.
  • 11 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q1 2023 and 30 closed out, a net change of -19 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q1 2023 was Fidelity Investments, an estimated $3.3M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q1 2023 was Millennium Management, an estimated $3.83M sold.

Based on aggregated 13F filings for Q1 2023.